Journal article

Management of Urosepsis in 2018


Authors listBonkat, Gernot; Cai, Tomasso; Veeratterapillay, Rajan; Bruyere, Franck; Bartoletti, Riccardo; Pilatz, Adrian; Koves, Bela; Geerlings, Suzanne E.; Pradere, Benjamin; Pickard, Robert; Wagenlehner, Florian M. E.

Publication year2019

Pages5-9

JournalEuropean Urology Focus

Volume number5

Issue number1

eISSN2405-4569

DOI Linkhttps://doi.org/10.1016/j.euf.2018.11.003

PublisherElsevier


Abstract

Despite optimal treatment, urosepsis has still high morbidity and mortality rates. An updated definition and classification system for sepsis have recently been introduced. Management of urosepsis comprises four major aspects: (1) early diagnosis, (2) early empiric intravenous antimicrobial treatment, (3) identification and control of complicating factors, and (4) specific sepsis therapy. The quick sequential organ failure assessment is replacing the systemic inflammatory response syndrome scoring for rapid identification of patients with urosepsis.

Patient summary: Urosepsis is a serious, life-threatening complication of infections originating from the urinary tract. As urosepsis has a very high mortality rate, it is important that is quickly spotted and that appropriate treatment is swiftly begun. Imaging of urinary tract disorders has been shown to be useful in decreasing mortality from urosepsis, and in the future microbiology techniques may also prove useful. Given the severity of urosepsis and the associated risks, large efforts need to be made to prevent high-risk infections in hospitals with appropriate prevention measures, such as the early removal of catheters used whenever possible. (c) 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.




Citation Styles

Harvard Citation styleBonkat, G., Cai, T., Veeratterapillay, R., Bruyere, F., Bartoletti, R., Pilatz, A., et al. (2019) Management of Urosepsis in 2018, European urology focus, 5(1), pp. 5-9. https://doi.org/10.1016/j.euf.2018.11.003

APA Citation styleBonkat, G., Cai, T., Veeratterapillay, R., Bruyere, F., Bartoletti, R., Pilatz, A., Koves, B., Geerlings, S., Pradere, B., Pickard, R., & Wagenlehner, F. (2019). Management of Urosepsis in 2018. European urology focus. 5(1), 5-9. https://doi.org/10.1016/j.euf.2018.11.003



Keywords


ANTIMICROBIAL THERAPYPrevention measuresUrological infectionsUrosepsis

Last updated on 2025-21-05 at 18:24